<DOC>
	<DOC>NCT02797548</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of perioperative antiplatelet therapy in patients with drug-eluting stent undergoing non-cardiac surgery.</brief_summary>
	<brief_title>Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery</brief_title>
	<detailed_description>Subjects who can not be randomized due to any reason will be enrolled at observational group.</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Planned noncardiac surgery at least after 6 months of implantation of drug eluting stent Low or intermediate risk level surgery Written informed consent Acute coronary syndrome within 1 month Heart failure NYHA III to IV Contraindication to Aspirin On anticoagulant therapy Emergent surgery Cardiac surgery High bleeding risk surgeries, e.g., Intracranial surgery, Intraspinal surgery, Retinal surgery Pregnancy or breastfeeding Life expectancy less than 1year</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>drug-eluting stent</keyword>
	<keyword>antiplatelet therapy</keyword>
	<keyword>noncardiac surgery</keyword>
</DOC>